Advertisement

Topics

Trastuzumab Increases PFS in Women With HER2/neu Uterine Cancer

06:06 EDT 13 Jul 2018 | Medscape

This well-done study should prompt oncologists to consider adding trastuzumab to carboplatin-paclitaxel treatment for women with advanced HER2/neu-positive uterine cancer, says Dr Maurie Markman.
Medscape Oncology

Original Article: Trastuzumab Increases PFS in Women With HER2/neu Uterine Cancer

NEXT ARTICLE

More From BioPortfolio on "Trastuzumab Increases PFS in Women With HER2/neu Uterine Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...